Unknown

Dataset Information

0

Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors.


ABSTRACT: The present studies sought to define whether checkpoint kinase 1 (CHK1) inhibitors and poly(ADP-ribose) polymerase 1 (PARP1) inhibitors interact in vitro and in vivo to kill breast cancer cells. PARP1 and CHK1 inhibitors interacted to kill estrogen receptor (ER)+, ER+ fulvestrant-resistant, HER2+, or triple-negative mammary carcinoma cells in a manner that was not apparently affected by phosphatase and tensin homolog deleted on chromosome 10 functional status. Expression of dominant-negative CHK1 enhanced and overexpression of wild-type CHK1 suppressed the toxicity of PARP1 inhibitors in a dose-dependent fashion. Knockdown of PARP1 enhanced the lethality of CHK1 inhibitors in a dose-dependent fashion. PARP1 and CHK1 inhibitors interacted in vivo both to suppress the growth of large established tumors and to suppress the growth of smaller developing tumors; the combination enhanced animal survival. PARP1 and CHK1 inhibitors profoundly radiosensitized cells in vitro and in vivo. In conclusion, our data demonstrate that the combination of PARP1 and CHK1 inhibitors has antitumor activity in vivo against multiple mammary tumor types and that translation of this approach could prove to be a useful anticancer therapeutic approach.

SUBMITTER: Tang Y 

PROVIDER: S-EPMC3400842 | biostudies-other | 2012 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors.

Tang Yong Y   Hamed Hossein A HA   Poklepovic Andrew A   Dai Yun Y   Grant Steven S   Dent Paul P  

Molecular pharmacology 20120517 2


The present studies sought to define whether checkpoint kinase 1 (CHK1) inhibitors and poly(ADP-ribose) polymerase 1 (PARP1) inhibitors interact in vitro and in vivo to kill breast cancer cells. PARP1 and CHK1 inhibitors interacted to kill estrogen receptor (ER)+, ER+ fulvestrant-resistant, HER2+, or triple-negative mammary carcinoma cells in a manner that was not apparently affected by phosphatase and tensin homolog deleted on chromosome 10 functional status. Expression of dominant-negative CHK  ...[more]

Similar Datasets

| S-EPMC2981366 | biostudies-literature
2022-11-12 | GSE217587 | GEO
| S-EPMC4059819 | biostudies-literature
2022-11-12 | GSE217586 | GEO
2022-11-12 | GSE217585 | GEO
| S-EPMC4002295 | biostudies-literature
| S-EPMC7062869 | biostudies-literature
| S-EPMC4517072 | biostudies-literature
| S-EPMC4035043 | biostudies-literature
| S-EPMC6649553 | biostudies-literature